Skip to content

Clinical trials

Insulin Resistance trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: Spain Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20062
20081
20093
20103
20114
20133
20151
20163
20174
20185
20192
20204
20213
20226
20232
20244
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Unknown status6
Recruiting5
Not yet recruiting4
Active, not recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clinica Universidad de Navarra, Universidad de Navarra6
National Research Council, Spain4
Universidad Católica San Antonio de Murcia3
University of Castilla-La Mancha3
Celia Bañuls2
Eli Lilly and Company2
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal2
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2
Gan and Lee Pharmaceuticals, USA2
Hospital Universitari de Bellvitge2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance63
Obesity16
Diabetes Mellitus, Type 213
Metabolic Syndrome13
Diabetes Mellitus, Type 19
Inflammation9
Diabetes Mellitus8
Polycystic Ovary Syndrome6
Hyperandrogenism4
Hypertension4

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.